AQS — Aequus Pharmaceuticals Cashflow Statement
0.000.00%
- CA$2.65m
- CA$8.04m
- CA$0.25m
Annual cashflow statement for Aequus Pharmaceuticals, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.11 | -1.05 | -1.81 | -3.21 | -2.96 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.951 | 0.551 | 0.48 | 0.682 | 0.117 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.217 | -0.522 | 0.029 | 0.446 | 0.415 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.63 | -0.805 | -1.17 | -1.95 | -2.29 |
Capital Expenditures | -0.003 | -0.012 | -0.004 | 0 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | -0.504 | 0 | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.003 | -0.012 | -0.508 | 0 | — |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.75 | 2.05 | 2.4 | -0.189 | 2.21 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.115 | 1.23 | 0.718 | -2.14 | -0.08 |